Copyright
©2006 Baishideng Publishing Group Co.
World J Gastroenterol. Dec 28, 2006; 12(48): 7826-7831
Published online Dec 28, 2006. doi: 10.3748/wjg.v12.i48.7826
Published online Dec 28, 2006. doi: 10.3748/wjg.v12.i48.7826
Figure 1 Literature search and selection.
Figure 2 1In this study, metformin was compared with vitamin E.
We have included only the metformin-treated group, with biopsies at baseline and at the end of the study. RCT: Randomized controlled trial; NR: Not reported, NS: Not significant; NA: Not applied; QUICKI: Quantitative insulin sensitivity check index; HOMA: Homeostatic model assessment; KITT: K index of insulin tolerance test.
Figure 3 1Only seven patients in the treatment group.
Information about the control group is not available; 2This study reported anemia as an adverse effect, but numerical data are not available. NR: not reported; NA: not applied; HOMA: homeostatic model assessment.
- Citation: Chavez-Tapia NC, Barrientos-Gutierrez T, Tellez-Ávila FI, Sánchez-Ávila F, Montaño-Reyes MA, Uribe M. Insulin sensitizers in treatment of nonalcoholic fatty liver disease: Systematic review. World J Gastroenterol 2006; 12(48): 7826-7831
- URL: https://www.wjgnet.com/1007-9327/full/v12/i48/7826.htm
- DOI: https://dx.doi.org/10.3748/wjg.v12.i48.7826